Most Read This Week
- Weight Changes After Treatment With Semaglutide in Individuals With MASLD/MASH With or Without Type 2 Diabetes
- Intensive BP Control in Patients With Type 2 Diabetes
- Use of SGLT2 Inhibitors Reduces Epicardial Adipose Tissue More Effectively Compared With GLP-1 Agonists or Exercise in Patients With Type 2 Diabetes and/or Obesity
- Weight Maintenance Using Cost-Effective Antiobesity Medications After 1 Year of GLP-1 Receptor Agonist Therapy
- Effect of Sarcopenic Obesity on the Progression of Glycaemic Status in Middle-Aged and Older Adults Without Diabetes
Recently Updated
- Prevalence of Metabolic Syndrome Among Children and Adolescents With Obesity
- Use of SGLT2 Inhibitors Reduces Epicardial Adipose Tissue More Effectively Compared With GLP-1 Agonists or Exercise in Patients With Type 2 Diabetes and/or Obesity
- GLP-1 Enhances β-Cell Response to Protein Ingestion and Bariatric Surgery Amplifies It
- Incidence of Early-Onset Type 2 Diabetes and Sociodemographic Predictors of Complications
- Association Between Food Insecurity and Weight-Loss Efforts in Adults With Higher Weight